US Stock MarketDetailed Quotes
SCPH scPharmaceuticals
- 4.780
- +0.120+2.57%
Trading May 3 12:19 ET
172.34MMarket Cap-3366P/E (TTM)
4.840High4.740Low34.34KVolume4.760Open4.660Pre Close164.41KTurnover0.21%Turnover RatioLossP/E (Static)36.05MShares12.75052wk High4.63P/B78.86MFloat Cap4.25052wk Low--Dividend TTM16.50MShs Float18.170Historical High--Div YieldTTM2.15%Amplitude2.440Historical Low4.787Avg Price1Lot Size
About scPharmaceuticals Company
scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.
Company Profile
SymbolSCPH
Company NamescPharmaceuticals
Listing DateNov 17, 2017
Issue Price14.00
Founded2013
CEOMr. John H. Tucker
MarketNASDAQ
Employees136
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address25 Burlington Mall Road,Suite 203
CityBurlington
ProvinceMassachusetts
CountryUnited States of America
Zip Code01830
Phone1-617-517-0730
Company Executives
- Name
- Position
- Salary
- John H. Tucker
- Director, President and Chief Executive Officer
- 1.84M
- Rachael Nokes
- Principal Accounting Officer and Chief Financial Officer
- 724.20K
- Jack A. Khattar
- Chairman of the Board
- 227.05K
- Dr. Klaus Veitinger, M.D.,PhD
- Independent Director
- 187.05K
- Sara M. Bonstein
- Independent Director
- 187.05K
- Mette Kirstine Agger
- Independent Director
- 189.55K
- Dr. William T. Abraham, M.D.
- Independent Director
- 182.05K
- Minnie V. Baylor-Henry
- Independent Director
- 187.05K
- Leonard D. Schaeffer
- Independent Director
- 184.55K
- Frederick M. Hudson
- Independent Director
- 197.05K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg